Literature DB >> 3047469

Prevalence of fatty liver in a general population of Okinawa, Japan.

H Nomura1, S Kashiwagi, J Hayashi, W Kajiyama, S Tani, M Goto.   

Abstract

A total of 2,574 residents in Yaeyama District of Okinawa, Japan, were investigated using real time ultrasonography to determine the real prevalence of fatty liver in the general population and to define its associated factors. Overall prevalence of fatty liver was 14.0%. Prevalence of fatty liver in persons under 19 years old was only 1.2%, and increased with age to a maximum in persons 40-49 years of age and then decreased. For persons over 20 years old, obesity index and serum levels of triglyceride and total cholesterol were measured, and alcohol consumption was asked. Prevalence of fatty liver was significantly higher in drinkers than non-drinkers (p less than 0.01), and increased with alcohol consumption. Furthermore, in persons not suffering from obesity prevalence of fatty liver was significantly higher in drinkers than in non-drinkers (p less than 0.001). The results of logistic regression analysis indicated that obesity and elevated serum triglyceride level in both sexes, and alcohol in males were significant predictors of fatty liver. In conclusion, prevalence of fatty liver increased with age to a maximum in persons 40-49 years of age and overall was 14.0%. Obesity was the strongest associated factor in both sexes and in males alcohol was also a strong factor.

Entities:  

Mesh:

Year:  1988        PMID: 3047469     DOI: 10.2169/internalmedicine1962.27.142

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  70 in total

1.  The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease.

Authors:  Said A Al-Busafi; Peter Ghali; Philip Wong; Javier A Novales-Diaz; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

Review 3.  Nonalcoholic fatty liver disease: a clinical review.

Authors:  David A Sass; Parke Chang; Kapil B Chopra
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 4.  Nonalcoholic fatty liver disease and polycystic ovary syndrome.

Authors:  Evangeline Vassilatou
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 5.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

Review 6.  Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery.

Authors:  Andrea Lazzati; Antonio Iannelli; Anne-Sophie Schneck; Anaïs Charles Nelson; Sandrine Katsahian; Jean Gugenheim; Daniel Azoulay
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

7.  Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.

Authors:  Joel Z Stengel; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-06

8.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 9.  Hepatic steatosis and type 2 diabetes mellitus.

Authors:  Jeanne M Clark; Anna Mae Diehl
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 10.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.